Walking Routine Parameters Adults 40–65 Cohort
5.2 km/h (3.2 mph)
30 min/day
Mortality Risk Reduction
24.5%
vs. inactive baseline
Pace Category
Brisk Walking
~115 steps/min
Equiv. Weekly Distance
10.9 km
~6.8 miles/week
Pace Status
Optimal Brisk Pace
Meets target study zone
Dose-Response Longevity Curve Current: 5.2 km/h
Epidemiological dose-response curve showing mortality hazard reduction across walking speeds and daily time commitments.
Scientific Interpretation:
Walking at 5.2 km/h delivers an estimated 24.5% lower risk of premature mortality compared to inactive peers. Brisk walking stimulates sustained aerobic cardiovascular adaptation beyond casual strolls.